Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
06:15am, Wednesday, 14'th Aug 2024
The outlook for pharmaceutical stocks has been mixed in the last five years. During the pandemic, the early-movers in the vaccine race gained as compared to others.
AstraZeneca first London-listed company to surpass £200bn valuation
10:52am, Tuesday, 13'th Aug 2024
AstraZeneca PLC (LSE:AZN) has become the first UK-listed company to surpass a £200 billion stock market valuation after shares gained on Tuesday. Shares ticked up 1.2% to 12,928p throughout the day,
Conduit Pharmaceuticals enters into exclusive license agreement with AstraZeneca for HK-4 Glucokinase activators AZD1656 and AZD5658 targeting autoimmune indications and myeloperoxidase inhibitor AZD5
The Zacks Analyst Blog AstraZeneca, Ionis and Sanofi
05:05am, Tuesday, 06'th Aug 2024
AstraZeneca, Ionis and Sanofi are included in this Analyst Blog.
Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market
10:07am, Sunday, 04'th Aug 2024
AstraZeneca's CEO has a vision for the weight loss drugs market. There probably won't be one medicine that's useful in every niche.
AstraZeneca falls after UK drug watchdog blocks NHS access to Enhertu drug
05:49am, Tuesday, 30'th Jul 2024
AstraZeneca PLC (LSE:AZN) shares fell more than 1.7% on Tuesday after the English healthcare watchdog said that it could not recommend the drug company's breast cancer drug for the NHS. The National
Pharma companies less concerned after hearing from US on negotiated prices for Medicare
01:37pm, Monday, 29'th Jul 2024
Four pharmaceutical companies involved in the first U.S. negotiations over prices for the Medicare program said they do not expect a significant impact on their businesses after seeing confidential su
AstraZeneca shows promise in phase III study
03:46am, Monday, 29'th Jul 2024
A new combination treatment has shown significant improvement in treating chronic lymphocytic leukaemia (CLL) in a recent clinical trial. The AMPLIFY Phase III study found that a fixed duration of As
3 Surprisingly Underrated Stocks to Buy Right Now
12:25pm, Friday, 26'th Jul 2024
AstraZeneca is a healthcare giant trading at a discount. There's more to the story with Pfizer than its COVID woes and looming patent cliff.
Europe's Markets Are Cheap. 4 Stocks to Play.
11:47am, Friday, 26'th Jul 2024
Nevertheless, its member economies are poised for a rebound.
AstraZeneca Shares Fall Despite EPS Beat and Raised Guidance
07:01am, Friday, 26'th Jul 2024
AstraZeneca PLC NASDAQ: AZN is a United Kingdom-based healthcare firm and the sixth-largest pharmaceutical company in the world by market capitalization. So far, in 2024, the firm has outperformed t
7 Explosive Growth Stocks Set to Soar in 2024
05:17pm, Thursday, 25'th Jul 2024
Wall Street has rewarded certain growth stocks handsomely this year. I believe now may be an opportune time to buy some of these high-flyers, even after the recent tech selloff.
AstraZeneca's CEO talks earnings, competition, China, and potential tariffs
02:14pm, Thursday, 25'th Jul 2024
AstraZeneca (AZN) reported a second-quarter earnings beat, raising their full-year guidance due to strong demand. However, the company faced some pressure in areas like operating costs.
Govt body's procedures means people with cancer aren't getting drug - AstraZeneca boss
11:56am, Thursday, 25'th Jul 2024
The chief executive of AstraZeneca has criticised a public health body for refusing to make one of its breast cancer treatments available to NHS patients in England and Wales.
Why AstraZeneca Stock Is Sliding Today
11:48am, Thursday, 25'th Jul 2024
AstraZeneca topped Wall Street revenue and earnings estimates. The big pharma company also raised its full-year revenue and earnings guidance.
